Ehrin J. Armstrong, MD, MSc, FACC

Bryan T. Fisher Sr., MD;

Constantino S. Pena , MD, FAHA, FSCCT, FSIR;

Arthur C. Lee , MD, FACC, FSCAI;

John H. Rundback , MD, FAHA, FSIR;

Mehdi H. Shishehbor , DO, MPH, PhD;

Clinical Outcomes and Cost Comparisons of Stent and Non-Stent Interventions in Infrainguinal Peripheral Artery Disease: Insights From the Excellence in Peripheral Artery Disease (XLPAD) Registry

Sahil A. Parikh , MD, FACC, FSCAI;

This review outlines a contemporary ultrasound-based approach to crossing femoropopliteal PCTOs based on a review of prospectively collected case report surveys, published evidence, and expert opinion compiled by the writing group members.

This review outlines a...

03/28/2019

Journal of Invasive Cardiology

Original Contribution

12/28/2018

Scott Kinlay , MD;

Mujtaba M. Ali , MD, RPVI;

Bala Ramanan , MD, MBBS;

Shirling Tsai , MD;

Emmanouil S. Brilakis , MD, PhD, FACC, FAHA, FESC, FSCAI;

Tayo Addo , MD;

Mazen S. Abu-Fadel , MD;

Christopher T. Bajzer , MD;

Ian M. Cawich , MD;

Houman Khalili , MD;

Michael Luna , MD;

Khusrow Niazi , MD;

Anand Prasad , MD, FACC, FSCAI, RPVI;

Short-Term Outcomes After Retrograde Versus Antegrade Crossing Approaches for Femoropopliteal Occlusive Disease

Nicolas W. Shammas , MD, MS, FACC, FSCAI, FACP, FSVM;

Osvaldo S. Gigliotti , MD;

Haekyung Jeon-Slaughter , PhD;

Bassel Bou Dargham , MD, BS;

Preeti Kamath , BDS, MHA;

Mazin I. Foteh , MD;

We present data on 2162 patients from the ongoing United States multicenter XLPAD registry between 2006-2016 to compare stent vs non-stent treatment outcomes and associated costs in FP interventions.

We present data on 2162 patients...

12/28/2018

Journal of Invasive Cardiology

Original Contribution

11/30/2022

Steven Meadors , MD;

Andrea Klein , MD;

Omar Jawaid , MD;

Rahul Banerjee ;

Mohamed Amer Alaiti , MD;

Gregory Modrall , MD;

Racial Disparities in Risk for Major Amputation or Death After Endovascular Interventions for Peripheral Artery Disease: A LIBERTY 360 Study

Haekyung Jeon-Slaughter , PhD;

Bala Ramanan , MD, MBBS;

Shirling Tsai , MD;

Few studies have directly compared procedural details and outcomes after retrograde vs antegrade crossing of FP lesions.

Few studies have directly...

11/30/2022

Journal of Invasive Cardiology

Original Contribution

05/28/2021

Dwight Dishmon , MD;

Laiq Raja , MD, FACC, FSCAI;

Foluso A. Fakorede , MD;

Intravascular Lithotripsy for Optimal Angioplasty of Infrapopliteal Calcified Lesions

Aaron Horne Jr., MD;

George L. Adams , MD, MHS, MBA, FACC, FSCAI;

Ian M. Cawich , MD;

Jihad A. Mustapha , MD, FACC, FSCAI;

The aim of this study was to determine whether there are racial differences in outcomes of patients with PAD undergoing endovascular treatment.

The aim of this study was to...

05/28/2021

Review

01/28/2022

The Nature of Dissections in Infrapopliteal Arteries: Insights from Intravascular Ultrasound Imaging

Infrapopliteal arterial disease results from 2 major etiologies: medial calcification and intimal atheromatous plaque. Lesion calcification constitutes one of the most widely encountered risk factors for percutaneous transluminal angioplasty...

Infrapopliteal arterial disease...

01/28/2022

Journal of Invasive Cardiology

Case Report

06/10/2020

Gail A. Shammas , BSN, BS , RN, BSc;

Concomitant Drug-Coated Balloon Angioplasty With Bail-Out Use of Eluvia Drug-Eluting Stent: Is There Any Downside to a Double Dose of Paclitaxel?

Waheeb John Shammas , BS, MBA, RA, BA;

Qais Radaideh , MD, MS;

Nicolas W. Shammas , MD, MS, FACC, FSCAI, FACP, FSVM;

Shammas and colleagues discuss how treatment of infrapopliteal arteries can be challenging due to the presence of medial calcinosis and fibrotic rings.

Shammas and colleagues discuss...

06/10/2020

Cath Lab Digest

Giannopoulos Drug-Eluting Stent Figure 1

Original Contribution

06/01/2022

Eric A. Secemsky , MD, MSc, RPVI, FACC, FAHA, FSCAI;

Contemporary Use of Laser During Percutaneous Coronary Interventions: Insights from the Laser Veterans Affairs (LAVA) Multicenter Registry

The application of 2 distinct and simultaneously applied drug-delivery platforms for the treatment of peripheral artery disease has not been studied. This study investigated the outcomes of femoropopliteal disease treated with drug-coated...

The application of 2 distinct...

06/01/2022

Journal of Invasive Cardiology

Original Contribution

03/15/2018

Aris Karatasakis , MD;

Barbara Anna Danek , MD;

Aya J. Alame , BA;

Judit Karacsonyi , MD, PhD;

José Roberto Martínez-Parachini , MD;

Michele Roesle , RN, BSN, MD;

Houman Khalili , MD;

Bavana V. Rangan , BDS, MPH, MD;

Procedural and 3-Year Outcomes of Peripheral Vascular Interventions Performed in Office-Based Labs: LIBERTY 360 Sub-Analysis

Imre Ungi , MD, PhD;

Emmanouil S. Brilakis , MD, PhD, FACC, FAHA, FESC, FSCAI;

Huu Tam D. Truong , MD;

Ryan Tsuda , MD;

Damianos G. Kokkinidis , MD;

We examined the baseline clinical and angiographic characteristics and procedural outcomes of 130 target lesions in 121 consecutive PCIs (n = 116 patients) in which excimer laser coronary atherectomy was performed at three United States...

We examined the baseline...

03/15/2018

Journal of Invasive Cardiology

Original Contribution

05/01/2021

George Pliagas , MD, FACS, FRCSC;

Comparative Effectiveness Study of Drug-Eluting and Bare-Metal Peripheral Artery Stents in Endovascular Femoropopliteal Artery Revascularization

Few data are available on the safety of interventions for peripheral arterial disease performed in the office-based laboratory (OBL) setting. Thus, the aim of this study was to investigate the short- and late-term outcomes of patients treated...

Few data are available on the...

05/01/2021

Journal of Invasive Cardiology

Original Contribution

09/30/2018

Osvaldo S. Gigliotti , MD;

Haekyung Jeon-Slaughter , PhD;

Shirling Tsai , MD;

Omar Jawaid , MD;

Hua Lu , MD;

Nicolas W. Shammas , MD, MS, FACC, FSCAI, FACP, FSVM;

Tayo Addo , MD;

Houman Khalili , MD;